Keybank National Association OH Purchases Shares of 2,171 Cardinal Health, Inc. (NYSE:CAH)

Keybank National Association OH purchased a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 2,171 shares of the company's stock, valued at approximately $257,000.

A number of other large investors have also recently bought and sold shares of CAH. Frazier Financial Advisors LLC grew its holdings in shares of Cardinal Health by 69.8% during the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after purchasing an additional 104 shares during the last quarter. AM Squared Ltd bought a new stake in shares of Cardinal Health during the third quarter worth $33,000. Kentucky Trust Co bought a new stake in shares of Cardinal Health during the fourth quarter worth $41,000. HHM Wealth Advisors LLC grew its holdings in shares of Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock worth $47,000 after purchasing an additional 144 shares during the last quarter. Finally, Raleigh Capital Management Inc. grew its holdings in shares of Cardinal Health by 29.6% during the fourth quarter. Raleigh Capital Management Inc. now owns 464 shares of the company's stock worth $55,000 after purchasing an additional 106 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CAH has been the topic of several research analyst reports. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price on the stock in a report on Tuesday, January 7th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and upped their price target for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Citigroup upped their price target on Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research note on Friday, January 10th. Finally, Morgan Stanley upped their price target on Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research note on Friday, January 31st. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $139.36.

Remove Ads

Cardinal Health Trading Up 0.3 %

NYSE:CAH opened at $124.25 on Wednesday. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $132.84. The business's 50-day moving average price is $125.82 and its two-hundred day moving average price is $119.08. The firm has a market capitalization of $30.01 billion, a price-to-earnings ratio of 23.18, a PEG ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.63%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's payout ratio is 37.69%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.